Actionable news
0
All posts from Actionable news
Actionable news in CELG: Celgene Corporation,

Birchview Capital, LP files portfolio update

Birchview Capital, LP just filed a portfolio update (also known as a 13-F), dated April 28, 2016. The portfolio holdings are as of March 31, 2016.

Birchview Capital, LP reported adding to its positions of:

  • Celgene Corporation
  • COLLEGIUM PHARMACEUTICAL, INC
  • Merrimack Pharmaceuticals
  • Neurocrine Biosciences
  • NxStage Medical
  • OncoMed Pharmaceuticals Inc
  • Oxford Immunotec Global
  • Roka BioScience, Inc.
  • Accelerate Diagnostics, Inc.

Positions in the following companies appear to have been reduced:

  • Cerus Corporation
  • Hansen Medical
  • Kura Oncology, Inc.
  • Medivation

It would appear as though Birchview Capital, LP sold all of its holdings in:

  • Agios Pharmac euticals Inc
  • Gilead Sciences
  • PTC Therapeutics

Brand new positions appear to have been established in:

  • GENOCEA BIOSCIENCES, INC.
  • Intercept Pharmaceuticals
  • Pacific Biosciences of California

Keep in mind, however, that typos are common in public filings, and that CUSIP numbers may not be accurate. Please verify the filing directly for confirmation of the above information.

To see Birchview Capital, LP's latest available portfolio, click here.